(MFC) Manulife Financial - Overview
Sector: Financial Services | Industry: Insurance - Life | Exchange: NYSE (USA) | Market Cap: 62.700m USD | Total Return: 22.7% in 12m
Life Insurance, Annuities, Asset Management, Banking, Reinsurance
Total Rating 45
Safety 37
Buy Signal -0.18
Insurance - Life
Industry Rotation: +2.7
Industry Rotation: +2.7
Market Cap:
62.7B
Avg Turnover: 67.1M
Avg Turnover: 67.1M
Risk 3d forecast
Volatility28.2%
VaR 5th Pctl4.85%
VaR vs Median4.53%
Reward TTM
Sharpe Ratio0.89
Rel. Str. IBD67
Rel. Str. Peer Group67.5
Character TTM
Beta0.935
Beta Downside0.888
Hurst Exponent0.423
Drawdowns 3y
Max DD16.75%
CAGR/Max DD1.88
CAGR/Mean DD8.77
EPS (Earnings per Share)
EPS CAGR: 8.52%
EPS Trend: 14.6%
EPS Trend: 14.6%
Last SUE: 1.55
Qual. Beats: 3
Qual. Beats: 3
Revenue
Rev. CAGR: 140.03%
Rev. Trend: 34.5%
Rev. Trend: 34.5%
Last SUE: 0.34
Qual. Beats: 0
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
Garp
Description: MFC Manulife Financial
Manulife Financial Corporation (MFC) is a diversified financial services provider headquartered in Toronto, operating primarily across North America and Asia. The company’s business model is structured into three main pillars: Wealth and Asset Management, Insurance and Annuity Products, and a Corporate segment that oversees reinsurance and legacy run-off operations. Beyond core life and health insurance, Manulife maintains a specialized presence in alternative long-term assets, including the management of timberland and agricultural portfolios.
The Life & Health Insurance sector is characterized by a high degree of sensitivity to interest rate fluctuations and credit spreads, which impact both investment yields and long-term liability valuations. As a global provider, Manulife utilizes a multi-channel distribution strategy that leverages independent brokers, financial planners, and institutional partnerships to scale its retail and retirement solutions. The company’s integrated banking services and asset management arm further diversify its revenue streams beyond traditional underwriting premiums.
Investors can further examine these financial metrics and valuation trends by visiting ValueRay.
- Asian market expansion drives core earnings growth and long-term revenue diversification
- Rising interest rates increase investment yields and improve life insurance margins
- Wealth and asset management inflows boost fee-based revenue and capital efficiency
- Management of long-term care legacy liabilities impacts capital reserve requirements
- Global equity market performance dictates assets under management and advisory income
Piotroski VR‑10 (Strict)
5.0
| Net Income: 6.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: 100.5% < 20% (prev 54.76%; Δ 45.75% < -1%) |
| CFO/TA 0.03 > 3% & CFO 28.96b > Net Income 6.42b |
| Net Debt (-1.08b) to EBITDA (8.26b): -0.13 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (1.21b) vs 12m ago -30.15% < -2% |
| Gross Margin: 33.34% > 18% (prev 0.78%; Δ 3.26k% > 0.5%) |
| Asset Turnover: 7.89% > 50% (prev 4.72%; Δ 3.17% > 0%) |
| Interest Coverage Ratio: 6.10 > 6 (EBITDA TTM 8.26b / Interest Expense TTM 1.54b) |
Altman Z''
0.64
| A: 0.08 (Total Current Assets 79.75b - Total Current Liabilities 0.0) / Total Assets 1029.17b |
| B: 0.00 (Retained Earnings 5.04b / Total Assets 1029.17b) |
| C: 0.01 (EBIT TTM 9.41b / Avg Total Assets 1005.29b) |
| D: 0.05 (Book Value of Equity 43.90b / Total Liabilities 928.25b) |
| Altman-Z'' Score: 0.64 = B |
What is the price of MFC shares?
As of May 20, 2026, the stock is trading at USD 37.82 with a total of 1,441,612 shares traded.
Over the past week, the price has changed by -5.52%, over one month by -1.92%, over three months by +5.61% and over the past year by +22.66%.
Over the past week, the price has changed by -5.52%, over one month by -1.92%, over three months by +5.61% and over the past year by +22.66%.
Is MFC a buy, sell or hold?
Manulife Financial has received a consensus analysts rating of 3.77.
Therefor, it is recommend to hold MFC.
- StrongBuy: 3
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MFC price?
| Analysts Target Price | 34.6 | -8.5% |
Manulife Financial (MFC) - Fundamental Data Overview
as of 19 May 2026
Market Cap CAD = 86.21b (62.70b USD * 1.3749 USD.CAD)P/E Trailing = 16.7723
P/E Forward = 12.0337
P/S = 1.9576
P/B = 2.0563
P/EG = 0.7785
Revenue TTM = 79.35b CAD
EBIT TTM = 9.41b CAD
EBITDA TTM = 8.26b CAD
Long Term Debt = 12.93b CAD (from longTermDebt, last fiscal year)
Short Term Debt = 1.74b CAD (from shortTermDebt, last fiscal year)
Debt = 13.48b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.08b CAD (from netDebt column, last quarter)
Enterprise Value = 85.12b CAD (86.21b + Debt 13.48b - CCE 14.56b)
Interest Coverage Ratio = 6.10 (Ebit TTM 9.41b / Interest Expense TTM 1.54b)
EV/FCF = 2.94x (Enterprise Value 85.12b / FCF TTM 28.96b)
FCF Yield = 34.01% (FCF TTM 28.96b / Enterprise Value 85.12b)
FCF Margin = 36.49% (FCF TTM 28.96b / Revenue TTM 79.35b)
Net Margin = 8.09% (Net Income TTM 6.42b / Revenue TTM 79.35b)
Gross Margin = 33.34% ((Revenue TTM 79.35b - Cost of Revenue TTM 52.89b) / Revenue TTM)
Gross Margin QoQ = none% (prev 76.01%)
Tobins Q-Ratio = 0.08 (Enterprise Value 85.12b / Total Assets 1029.17b)
Interest Expense / Debt = 2.89% (Interest Expense 390.0m / Debt 13.48b)
Taxrate = 15.69% (230.6m / 1.47b)
NOPAT = 7.93b (EBIT 9.41b * (1 - 15.69%))
Current Ratio = unknown (Total Current Assets 79.75b / Total Current Liabilities 0.0)
Debt / Equity = 0.27 (Debt 13.48b / totalStockholderEquity, last quarter 50.76b)
Debt / EBITDA = -0.13 (Net Debt -1.08b / EBITDA 8.26b)
Debt / FCF = -0.04 (Net Debt -1.08b / FCF TTM 28.96b)
Total Stockholder Equity = 50.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.64% (Net Income 6.42b / Total Assets 1029.17b)
RoE = 12.65% (Net Income TTM 6.42b / Total Stockholder Equity 50.75b)
RoCE = 14.77% (EBIT 9.41b / Capital Employed (Equity 50.75b + L.T.Debt 12.93b))
RoIC = 13.70% (NOPAT 7.93b / Invested Capital 57.88b)
WACC = 8.35% (E(86.21b)/V(99.69b) * Re(9.27%) + D(13.48b)/V(99.69b) * Rd(2.89%) * (1-Tc(0.16)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -17.85%
[DCF] Terminal Value 80.13% ; FCFF base≈28.82b ; Y1≈34.71b ; Y5≈56.05b
[DCF] Fair Price = 541.5 (EV 902.66b - Net Debt -1.08b = Equity 903.74b / Shares 1.67b; r=8.35% [WACC]; 5y FCF grow 21.84% → 3.0% )
EPS Correlation: 14.56 | EPS CAGR: 8.52% | SUE: 1.55 | # QB: 3
Revenue Correlation: 34.51 | Revenue CAGR: 140.0% | SUE: 0.34 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.09 | Chg30d=-2.36% | Revisions=-33% | Analysts=10
EPS next Quarter (2026-09-30): EPS=1.17 | Chg30d=-0.97% | Revisions=+11% | Analysts=10
EPS current Year (2026-12-31): EPS=4.47 | Chg30d=-1.26% | Revisions=+0% | GrowthEPS=+6.1% | GrowthRev=-5.6%
EPS next Year (2027-12-31): EPS=4.94 | Chg30d=-0.48% | Revisions=+27% | GrowthEPS=+10.5% | GrowthRev=-7.8%
[Analyst] Revisions Ratio: -33%